DE69910230D1 - Paclitaxel enthaltende arzneimittel - Google Patents
Paclitaxel enthaltende arzneimittelInfo
- Publication number
- DE69910230D1 DE69910230D1 DE69910230T DE69910230T DE69910230D1 DE 69910230 D1 DE69910230 D1 DE 69910230D1 DE 69910230 T DE69910230 T DE 69910230T DE 69910230 T DE69910230 T DE 69910230T DE 69910230 D1 DE69910230 D1 DE 69910230D1
- Authority
- DE
- Germany
- Prior art keywords
- products containing
- medicinal products
- containing paclitaxel
- paclitaxel
- long term
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/165,930 US5922754A (en) | 1998-10-02 | 1998-10-02 | Pharmaceutical compositions containing paclitaxel |
US165930 | 1998-10-02 | ||
PCT/US1999/021024 WO2000020036A1 (en) | 1998-10-02 | 1999-09-14 | Pharmaceutical compositions containing paclitaxel |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69910230D1 true DE69910230D1 (de) | 2003-09-11 |
DE69910230T2 DE69910230T2 (de) | 2004-06-09 |
Family
ID=22601068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69910230T Expired - Fee Related DE69910230T2 (de) | 1998-10-02 | 1999-09-14 | Paclitaxel enthaltende arzneimittel |
Country Status (11)
Country | Link |
---|---|
US (1) | US5922754A (de) |
EP (1) | EP1117440B1 (de) |
JP (1) | JP2002526424A (de) |
AT (1) | ATE246514T1 (de) |
AU (1) | AU759034B2 (de) |
CA (1) | CA2345729A1 (de) |
DE (1) | DE69910230T2 (de) |
DK (1) | DK1117440T3 (de) |
ES (1) | ES2205879T3 (de) |
PT (1) | PT1117440E (de) |
WO (1) | WO2000020036A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR1000347B (el) * | 1988-12-21 | 1992-06-25 | Ortho Diagnostic Systems Inc | Μεθοδος παραγωγης νουκλεοτιδικων ανιχνευτων χρησιμοποιωντας ενα συμπληρωμα γεφυρωσεως. |
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
KR100330373B1 (ko) * | 1996-05-28 | 2002-11-07 | 주식회사한국신약 | 탁솔을 함유한 주사용 약제 조성물 |
KR19990075621A (ko) * | 1998-03-23 | 1999-10-15 | 임성주 | 경사 평판형 배양조 |
US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
JP2003521545A (ja) | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 改良された溶解性を有するタキサン製剤 |
US8618085B2 (en) * | 2000-04-28 | 2013-12-31 | Koasn Biosciences Incorporated | Therapeutic formulations of desoxyepothilones |
EP1280557B1 (de) | 2000-05-12 | 2012-06-20 | Samyang Corporation | Methode für die herstellung von polymermizellen vermittels phasentrennung eines block-copolymers |
US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
KR100774366B1 (ko) * | 2001-09-10 | 2007-11-08 | 주식회사 중외제약 | 파클리탁셀 주사제 조성물 |
EP1461056A4 (de) * | 2001-11-26 | 2006-01-25 | Supergen Inc | Verfahren zur herstellung und verwendung von polyoxyethyliertem rizinusöl in pharmazeutischen zusammensetzungen |
US20060078618A1 (en) * | 2001-12-11 | 2006-04-13 | Constantinides Panayiotis P | Lipid particles and suspensions and uses thereof |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
ATE512674T1 (de) * | 2003-01-06 | 2011-07-15 | Angiochem Inc | Angiopep-1, verwandte verbindungen, und deren verwnedungen |
ES2383901T5 (es) * | 2005-02-18 | 2015-02-25 | Angiochem Inc. | Polipéptidos de aprotinina para transportar un compuesto a través de la barrera sangre-cerebro |
US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
EP1904052A4 (de) * | 2005-06-17 | 2008-12-10 | Hospira Australia Pty Ltd | Flüssige pharmazeutische formulierungen von docetaxel |
EP2233156B1 (de) | 2005-07-15 | 2013-05-01 | Angiochem Inc. | Verwendung von Aprotinin-Polypeptiden als Träger in pharmazeutischen Konjugaten |
AR054215A1 (es) | 2006-01-20 | 2007-06-13 | Eriochem Sa | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
US20100056520A1 (en) * | 2006-10-31 | 2010-03-04 | Frances Anne Donahue | Formulations of phospholipase enzyme inhibitors |
US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
WO2009047794A2 (en) * | 2007-10-01 | 2009-04-16 | Intas Pharmaceuticals Limited | Taxane derivative composition |
AR063111A1 (es) | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
US20090098168A1 (en) * | 2007-10-08 | 2009-04-16 | The Regents Of The University Of California | Multiple-layer microbubble liposphere drug delivery vehicle and system |
KR101053780B1 (ko) * | 2008-02-29 | 2011-08-02 | 동아제약주식회사 | 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물 |
ES2721148T3 (es) * | 2008-04-18 | 2019-07-29 | Angiochem Inc | Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso |
ES2344674B1 (es) | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
WO2010023321A1 (en) * | 2008-09-01 | 2010-03-04 | Stragen Pharma S.A. | Liquid formulation containing a taxane derivative |
BRPI0920209A2 (pt) | 2008-10-15 | 2015-12-22 | Angiochem Inc | conjugados de agonistas de glp-1 e usos dos mesmos |
CN102245636A (zh) | 2008-10-15 | 2011-11-16 | 安吉奥开米公司 | 用于药物递送的依托泊苷和多柔比星结合物 |
AU2009322043A1 (en) | 2008-12-05 | 2011-07-07 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
US7862716B2 (en) * | 2009-04-13 | 2011-01-04 | Sielc Technologies Corporation | HPLC schematic with integrated sample cleaning system |
EP2421562B1 (de) | 2009-04-20 | 2019-03-13 | Angiochem Inc. | Behandlung von ovarialkarzinom mit einem an ein angiopep-2-analogon konjugierten antitumorwirkstoff |
CN102596993A (zh) | 2009-07-02 | 2012-07-18 | 安吉奥开米公司 | 多聚体肽结合物以及其应用 |
FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
CN102151243B (zh) * | 2010-12-29 | 2013-06-05 | 辰欣药业股份有限公司 | 一种紫杉醇注射液及其制备方法 |
CN103330941B (zh) * | 2013-07-15 | 2014-11-19 | 贺金凤 | 一种紫杉醇注射剂的药物组合物 |
US20160346219A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
CA2989400A1 (en) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Ang1005 for the treatment of leptomeningeal carcinomatosis |
TWI752750B (zh) * | 2015-09-30 | 2022-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2125279A1 (en) * | 1991-12-10 | 1993-06-24 | John Sayler Coon | Methods and compositions for reducing multi-drug resistance |
DE69320206T2 (de) * | 1992-11-27 | 1999-02-11 | Napro Biotherapeutics Inc | Paclitaxel enthaltende injizierbare zusammensetzung |
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
PL319511A1 (en) * | 1994-10-05 | 1997-08-18 | Glaxo Wellcome Inc | Parenteral pharmaceutic compositions containing gf120918a |
US5681846A (en) * | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
CN1209059A (zh) * | 1995-12-21 | 1999-02-24 | 基因实验室技术有限公司 | 紫杉烷类组合物及方法 |
ES2219895T3 (es) * | 1997-07-29 | 2004-12-01 | PHARMACIA & UPJOHN COMPANY | Formulacion autoemulsionante para compuestos lipofilos. |
-
1998
- 1998-10-02 US US09/165,930 patent/US5922754A/en not_active Expired - Fee Related
-
1999
- 1999-09-14 EP EP99945661A patent/EP1117440B1/de not_active Expired - Lifetime
- 1999-09-14 ES ES99945661T patent/ES2205879T3/es not_active Expired - Lifetime
- 1999-09-14 AU AU58225/99A patent/AU759034B2/en not_active Ceased
- 1999-09-14 WO PCT/US1999/021024 patent/WO2000020036A1/en active IP Right Grant
- 1999-09-14 PT PT99945661T patent/PT1117440E/pt unknown
- 1999-09-14 AT AT99945661T patent/ATE246514T1/de not_active IP Right Cessation
- 1999-09-14 JP JP2000573394A patent/JP2002526424A/ja not_active Withdrawn
- 1999-09-14 DE DE69910230T patent/DE69910230T2/de not_active Expired - Fee Related
- 1999-09-14 DK DK99945661T patent/DK1117440T3/da active
- 1999-09-14 CA CA002345729A patent/CA2345729A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE246514T1 (de) | 2003-08-15 |
EP1117440B1 (de) | 2003-08-06 |
DK1117440T3 (da) | 2003-12-01 |
PT1117440E (pt) | 2003-12-31 |
AU5822599A (en) | 2000-04-26 |
EP1117440A1 (de) | 2001-07-25 |
DE69910230T2 (de) | 2004-06-09 |
AU759034B2 (en) | 2003-04-03 |
US5922754A (en) | 1999-07-13 |
ES2205879T3 (es) | 2004-05-01 |
WO2000020036A1 (en) | 2000-04-13 |
JP2002526424A (ja) | 2002-08-20 |
CA2345729A1 (en) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69910230D1 (de) | Paclitaxel enthaltende arzneimittel | |
IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
FI964681A0 (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
NO20012774D0 (no) | Preparat og metode hvor det gjöres bruk av eteriske planteoljer | |
DK1329456T3 (da) | Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme | |
CY1105896T1 (el) | Χρησιμοποιηση ιδεβενονης δια την προστασια σκευασματων | |
SE0102315D0 (sv) | Compounds | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
TR200103575T2 (tr) | Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler | |
DE60027326D1 (de) | Maca und geweih zur steigerung des testosteronspiegels | |
ATE324150T1 (de) | Körperpflegemittel | |
ATE314084T1 (de) | Kahalalid f formulierung | |
SE9802937D0 (sv) | Novel compounds | |
ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
BR0210160A (pt) | Composições de fragâncias e flavorizantes | |
SE0001916D0 (sv) | Novel formulation | |
NO20032597D0 (no) | Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma | |
IT1318401B1 (it) | Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono. | |
ATE228300T1 (de) | Wirkstoffhaltige polyetherblockamide | |
DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
NO20021429L (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
IT1254452B (it) | N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli | |
BR9806851A (pt) | ComposiçÊes farmaceuticas e alimenticias que contêm bactérias de gênero acetobacter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |